Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Illinois State University Use NTA in the Development of Novel Bioanalytical Assays

Published: Friday, March 15, 2013
Last Updated: Friday, March 15, 2013
Bookmark and Share
Development of novel bioanalytical assays to detect nucleic acids, proteins, and whole viruses.

NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being used in the development of novel bioanalytical assays at Illinois State University.

The main application is the characterization of gold nanoparticles and differentiation between monodisperse samples from small numbers of aggregated materials.

Speeding up the detection and identification of viruses is one of the areas of new research of Illinois State University Assistant Professor of Chemistry Jeremy Driskell.

This has been recognized by the US Department of Defense in their recent award of a major grant. Reliable and accurate nanoparticle composition is important in such work.

Here, Dr Driskell describes how he has used various techniques.

Talking about his current work, Dr Driskell says "Our research group is focused on the development of novel bioanalytical assays which includes detection of nucleic acids, proteins, and whole viruses. While other groups aim to improve assay sensitivity or detection limits, our central focus is on reducing assay speed and complexity. We are currently using gold nanoparticles and gold filters to develop assays utilizing surface-enhanced Raman spectroscopy for detection. In the process of characterizing the gold nanoparticles and monitoring the modification steps required for the SERS assays, we found that particle sizing techniques such as Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) could also be used for assay readout. This finding and application is detailed in our recent publication in the Analyst."

Dr Driskell continued: "We began by using DLS to characterize gold nanoparticles that we modify with Raman reporter molecules and antibodies. This was a simple means of detecting particle aggregation as a result of surface modification and is more sensitive than colorimetric detection, which we found was not useful for conditions that invoked slight aggregation. When we learned of NanoSight and NTA, we compared the data to DLS. For our purposes, NTA gave a much more accurate representation of the actual particle sizes in our solutions. DLS would frequently indicate aggregation of a nanoparticle population while NTA revealed few large aggregates while the majority of the particles remained monodisperse. Ultimately we concluded it was a better technique to give us a better understanding of nanoparticle composition (aggregates compared with individual particles) in terms of absolute numbers."

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Method Development to Estimate the Purity of Vesicle Preparations
Nanoparticle tracking analysis is used to estimate the purity of vesicle preparations at the Cardiff University School of Medicine.
Thursday, February 28, 2013
NanoSight Announce New Appointment
Leading UK scientist, Dr Andrew Shuttleworth, joins NanoSight board as Director of Diagnostic Sciences.
Tuesday, June 26, 2012
Landmark Publication Reports Potential of Exosomes as Biomarkers for Early Disease Detection
NanoSight reports the new publication in one of the most cited peer reviewed journals in nanoscience and nanotechnology, NanoMedicine.
Thursday, July 07, 2011
NanoSight announces interactive webinar on January 27th on Exosome Characterization by Nanoparticle Tracking Analysis
NanoSight, world-leading manufacturers of unique nanoparticle characterization technology, will host an interactive webinar on the subject of exosome characterization by Nanoparticle Tracking Analysis.
Thursday, January 20, 2011
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Startup Seeks More Precise Prostate Cancer Screening
Gregor Diagnostics aims to bring a non-invasive prostate cancer screening test to the market.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Rare Immunodeficiency Yields Unexpected Insights
Scientists uncover previously unknown gene mutation revealing the role of a key molecule involved in immune cell development.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
IU Research Reveals Link between Molecular Mechanisms in Prostate Cancer and Ewing's sarcoma
Researchers at IU have suggested that the molecular mechanism that triggers the rare disease Ewing's sarcoma could act as a potential new direction for the treatment of more than half of patients with prostate cancer.
Smartphone Laboratory Detects Cancer
Researchers develop low-cost, portable laboratory on a smartphonecapable of analysing multiple samples simultaneously.
RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Advances in Alzheimer’s Research
Researchers show how a diseased vertebrate brain can naturally react to Alzheimer’s pathology by forming more neurons.
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos